Search Results Search Sort by RelevanceMost Recent Letter to the Editor Oct 2019 Response to “Will We Code for Default ECMO?”: Clarifying the Scope of Do-Not-ECMO Orders Jacob A. Blythe, MA, Sarah E. Wieten, PhD, and Jason N. Batten, MD, MA The authors further consider the merits of preventing ECMO from becoming a default treatment. AMA J Ethics. 2019;21(10):E926-929. doi: 10.1001/amajethics.2019.926. Health Law Aug 2006 Accutane and the Evolution of a Warning Lee Black, LLM The practice of informed consent has played a critical role in the evolution of the use of isotretinoin therapy and appropriate warning labels. Virtual Mentor. 2006;8(8):520-523. doi: 10.1001/virtualmentor.2006.8.8.hlaw1-0608.
Letter to the Editor Oct 2019 Response to “Will We Code for Default ECMO?”: Clarifying the Scope of Do-Not-ECMO Orders Jacob A. Blythe, MA, Sarah E. Wieten, PhD, and Jason N. Batten, MD, MA The authors further consider the merits of preventing ECMO from becoming a default treatment. AMA J Ethics. 2019;21(10):E926-929. doi: 10.1001/amajethics.2019.926.
Health Law Aug 2006 Accutane and the Evolution of a Warning Lee Black, LLM The practice of informed consent has played a critical role in the evolution of the use of isotretinoin therapy and appropriate warning labels. Virtual Mentor. 2006;8(8):520-523. doi: 10.1001/virtualmentor.2006.8.8.hlaw1-0608.